Metagenomi, Inc. Common Stock (MGX) — Strategic Asset Allocation Index
Metagenomi, Inc. Common Stock (MGX) has a Strategic Asset Allocation Index of 1.9% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $2.15 Million) total $2.15 Million, measured against net assets of $112.57 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MGX equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Metagenomi, Inc. Common Stock Strategic Asset Allocation Index (2024–2025)
This chart shows how Metagenomi, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 1.9%, representing strategic assets of $2.15 Million against net assets of $112.57 Million USD. For live market cap and overall valuation, see MGX company net worth.
Annual Strategic Asset Allocation Index for Metagenomi, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Metagenomi, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Metagenomi, Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.4% | $2.15 Million | $- | $2.15 Million | $158.60 Million | ▼ -0.1 pp |
| 2024 | 1.5% | $3.45 Million | $- | $3.45 Million | $234.86 Million | — |